6621 Fannin Street, Suite WB110.06
Houston, TX 77030
Sridevi Devaraj, PhD, DABCC, FACB
Medical Director of Clinical Chemistry and POCT, Texas Childrens Hospital
Professor of Pathology and Immunology, Baylor College of Medicine
Gregory Buffone, PhD, DABCC
Director of Laboratories, Texas Children’s Hospital
Professor Pathology, Baylor College of Medicine
Faculty and Research Interests
Obesity, Metabolic Syndrome, Diabetes, Management, Quality Improvement, Nutrition, Biomarkers of Disease, Hemoglobinopathies, Coagulation
|Perumal Thiagarajan||VA Medical Center|
|Roger Bertholf||Methodist Hospital|
|Qing Meng||UT MD Anderson|
Level(s) of training: Post PhD or MD
Number of positions available per year: 1
Duration of program: 2 years
Current number of trainees: 1
Number of past graduates: New Program
Institution Information URL: https://www.bcm.edu/departments/pathology-and-immunology/index.cfm?pmid=25552
Send letter of interest, CV and names of 3 references ot Program Director via email
The candidate for admission to the program should have a doctoral or medical degree(s) in either chemistry, biochemistry, biology, medicine, pathology, pathobiology, pharmacology, from an accredited university in the US or if overseas, be approved by an appropriate education evaluation agency. One should have had sufficient courses in analytical, inorganic, organic, physical, and biochemistry to qualify for certification by the American Board for Clinical Chemistry.
Deadline: October 1
The major goal of this 2-year training at the postdoctoral level is to prepare a clinical chemist trainee with sufficient clinical and practical experience to be an assistant/associate director of a Clinical Chemistry laboratory.
The mission and primary objective of this program is to train the postdoctoral clinical chemistry fellow in all aspects of clinical chemistry including general chemistry, endocrinology, toxicology, immunology. In addition, trainees will be able to get in-depth training in pediatric clinical chemistry. Trainees will spend the first year of training in the different areas of clinical chemistry listed above. In the second year, trainees will be involved with teaching, training new fellows and be involved in on-call duties for clinical chemistry and will focus on developing expertise in service, management and will be heavily involved with research and development. They will be expected to take the ABCC examinations towards the end of their second year of training to become certified by the ABCC. In addition, they may be interested in subsequently becoming eligible for certification in toxicological chemistry, and/or molecular diagnostics.